Farmakoterapie kognitivní dysfunkce u schizofrenie

Warning

This publication doesn't include Faculty of Arts. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English Pharmacotherapy for Cognitive Dysfunction in Schizophrenia
Authors

ČEŠKOVÁ Eva KUČEROVÁ Hana KAŠPÁREK Tomáš PŘIKRYL Radovan

Year of publication 2006
Type Article in Periodical
Magazine / Source Česká a slovenská psychiatrie
MU Faculty or unit

Faculty of Medicine

Citation
Field Psychiatry, sexuology
Keywords cognitive dysfunction; first-episode schizophrenia; atypical antipsychotics; adjunctive treatment; augmentation
Description Cognitive dysfunction is found in many neuropsychiatric disorders. It becomes the centre of attention for many reasons, mainly it is a very important factor influencing the functioning of the patients. The cognitive dysfunction involves several components, which are associated with a certain anatomical and functional substrate. Most studies were performed in patients with schizophrenia. The available pharmacotherapeutic possibilities include atypical antipsychotics and adjunctive treatment, which can further augment the effects of atypicals. The atypicals differ by their pharmacological profile,and this is also reflected in the differentiated effects on individual components. In comparison with typicals, atypical antipsychotics improve cognitive dysfunction more.The augmentation of basal neurotransmitters related to cognitive dysfunction(noradrenaline,acetylcholine, glutamate)and serotonin receptor modulators are studied. The cholinergic augmentation is primarily studied in dementia.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.